Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Tesson

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Disease Models & Mechanisms|July 9, 2024
The preclinical gap in pancreatic cancer and radiotherapyMathias Tesson, Jennifer P Morton
Oncotarget|October 15, 2017
Cell cycle specific radiosensitisation by the disulfiram and copper complexMathias Tesson, Giorgio Anselmi, Caitlin Bell, et al.
EJNMMI Research|November 14, 2013
Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen speciesColin Rae, Mathias Tesson, John W Babich, et al.
The Journal of Pharmacy and Pharmacology|May 4, 2016
Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugsMathias Tesson, Colin Rae, Colin Nixon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 26, 2013
The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cellsColin Rae, Mathias Tesson, John W Babich, et al.
Oncotarget|July 19, 2018
An evaluation <i>in vitro</i> of the efficacy of nutlin-3 and topotecan in combination with <sup>177</sup>Lu-DOTATATE for the treatment of neuroblastomaMathias Tesson, Richa Vasan, Andreas Hock, et al.
British Journal of Cancer|September 23, 2016
The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR aloneEsther J Campbell, Mathias Tesson, Flora Doogan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2012
Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporterAnthony G McCluskey, Robert J Mairs, Mathias Tesson, et al.
Disease Models & Mechanisms|February 29, 2024
Targeted irradiation in an autochthonous mouse model of pancreatic cancerMathias Tesson, Katrina Stevenson, Saadia A Karim, et al.
Non-Coding RNA|June 5, 2018
Epstein-Barr Virus EBER Transcripts Affect miRNA-Mediated Regulation of Specific Targets and Are Processed to Small RNA SpeciesJulia Alles, Daniele Hasler, Syed Mohammad Ali Kazmi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Disease Models & Mechanisms|July 9, 2024
The preclinical gap in pancreatic cancer and radiotherapyMathias Tesson, Jennifer P Morton
Oncotarget|October 15, 2017
Cell cycle specific radiosensitisation by the disulfiram and copper complexMathias Tesson, Giorgio Anselmi, Caitlin Bell, et al.
EJNMMI Research|November 14, 2013
Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen speciesColin Rae, Mathias Tesson, John W Babich, et al.
The Journal of Pharmacy and Pharmacology|May 4, 2016
Preliminary evaluation of prostate-targeted radiotherapy using (131) I-MIP-1095 in combination with radiosensitising chemotherapeutic drugsMathias Tesson, Colin Rae, Colin Nixon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 26, 2013
The role of copper in disulfiram-induced toxicity and radiosensitization of cancer cellsColin Rae, Mathias Tesson, John W Babich, et al.
Oncotarget|July 19, 2018
An evaluation <i>in vitro</i> of the efficacy of nutlin-3 and topotecan in combination with <sup>177</sup>Lu-DOTATATE for the treatment of neuroblastomaMathias Tesson, Richa Vasan, Andreas Hock, et al.
British Journal of Cancer|September 23, 2016
The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR aloneEsther J Campbell, Mathias Tesson, Flora Doogan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 13, 2012
Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporterAnthony G McCluskey, Robert J Mairs, Mathias Tesson, et al.
Disease Models & Mechanisms|February 29, 2024
Targeted irradiation in an autochthonous mouse model of pancreatic cancerMathias Tesson, Katrina Stevenson, Saadia A Karim, et al.
Non-Coding RNA|June 5, 2018
Epstein-Barr Virus EBER Transcripts Affect miRNA-Mediated Regulation of Specific Targets and Are Processed to Small RNA SpeciesJulia Alles, Daniele Hasler, Syed Mohammad Ali Kazmi, et al.
Pageof 2